Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Seres Therapeutics (MCRB) in Focus: Stock Up 5.5% in Session

Seres Therapeutics, Inc. MCRB was a big mover last session, as the company saw its shares rise around 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 27.5% since Mar 28, 2016.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Seres Therapeutics currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is negative.

A better-ranked stock in the same industry is Actelion Ltd. ALIOF, sporting a Zacks Rank #1 (Strong Buy).

Is MCRB going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ACTELION LTD (ALIOF): Free Stock Analysis Report
 
SERES THERAPEUT (MCRB): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research